Five cases of pneumocystis carinii pneumonia were diagnosed in adult patients following intensive chemotherapy in the Royal Group of Hospitals haematology unit, Belfast, within a space ofsix months. The common features and the risk factors contributing to the increased susceptibility of these patients are discussed, as are the likely mechanisms of transmission of infection.
INTRODUCTION
Pneumocystis carinii pneumonia (PCP) is a potentially life-threatening opportunistic infection. It was first recognised in Europe as a distinct clinical entity in children immunesuppressed by malnourishment during the Second World War. There was renewed interest in pneumocystis in the early 1980s when it became recognised as the AIDS defining pulmonary infection. Pneumocystis is a unicellular organism discovered by Chagas in 1909. It was subsequently shown to be a fungus as a result of RNA sequencing.1 There are recent reports ofincreasing incidence of this infection following organ transplantation due to high-dose immunosuppressive agents. We report a cluster of five suspected cases of pneumocystis carinii pneumonia in the regional haematology unit, Royal Group of Hospitals, Belfast, between August 1995 and February 1996. Case records for these patients were retrieved and studied in detail. Clinical course, treatment and survival outcome were followed up. We also review the literature on this subject and compare it with our own experience.
Patient 1 (index case)
A 28-year-old male with acute monocytic leukaemia presented with lethargy and bone pain. He achieved complete remission following the first course of chemotherapy MAE 3+10+5 (Mitozantrone 12 mg/M2 daily i.v. on days 1, 3 and 5; cytarabine 100 mg/m2 12 hourly i.v. on days 1-10 inclusive, and etoposide 100 mg/M2 daily i.v. on days 1-5 inclusive). He A 36-year-old male with multiple myeloma was treated with four courses of chemotherapy (vincristine, adriamycin and dexamethasone) followed by allogeneic bone marrow transplantation. Methotrexate, cyclosporin and prednisolone were used to prevent graft versus host disease. He received cytomegalovirus specific intravenous immunoglobulin and prophylactic co-trimoxazole. He experienced occasional nausea and vomiting after transplantation but tried his best to comply with his medication. Ten weeks later he became unwell, with shortness of breath on exertion, pyrexia and cough productive of purulent sputum. On examination he had sinus tachycardia and basal crepitations at both lung bases. Chest radiograph showed bilateral chronic inflammatory changes. Computed tomography revealed peripheral ill- The common features of the above patients are summarised below:
1. All had intensive chemotherapy which had been started at least 6 weeks before developing PCP.
2. All had been on a corticosteroid.
3. All showed a transient elevation in lactate dehydrogenase level (LDH) during pneumocystis infection without evidence of underlying disease recurrence (Table I ). 
